The "Oncology Based In-Vivo CRO Market Analysis, By Model, By Indication, and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
The oncology based in-vivo CRO market size is estimated to be USD 998.96 million in 2021 and is expected to witness a CAGR of 8.75% during the forecast period 2022-2029. The rising frequency with which big pharmaceutical companies outsource their R&D operations and increasing CROs' demand are projected to drive the market growth in near future. However, increased cost of cancer medications and their negative side effects are expected to restrain the market growth.
Segmentation: Oncology Based In-Vivo CRO Market Report 2021-2029 Model (Revenue, USD Million)
- Xenograft
- Syngeneic model
Indication (Revenue, USD Million)
- Solid Tumors
- Blood Cancer
By Region (Revenue, USD Million)
North America
- U.S
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Key Topics Covered:
1. Research Methodology
2. Introduction: Oncology Based In-Vivo CRO
3. Executive Summary
4. Market Dynamics
5. Market Environment Analysis
6. COVID-19 Impact Analysis: Oncology Based In-Vivo CRO Market
7. Market Analysis by Model
8. Market Analysis by Indication
9. Regional Market Analysis
10. North America Oncology Based In-Vivo CRO Market
11. Europe Oncology Based In-Vivo CRO Market
12. Asia Pacific Oncology Based In-Vivo CRO Market
13. Latin America Oncology Based In-Vivo CRO Market
14. MEA Oncology Based In-Vivo CRO Market
15. Competitor Analysis
16. Company Profiles
17. Conclusion & Recommendations
Companies Mentioned
- Toxikon Inc.
- Biosciences
- ICON Plc
- Covance
- Charles River Laboratory (CRL)
- Crown Bioscience
- Eurofins Scientific
- Taconic
- The Jackson Laboratory
- WuXi AppTec
For more information about this report visit https://www.researchandmarkets.com/r/43l4l1
View source version on businesswire.com: https://www.businesswire.com/news/home/20221005005427/en/
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
